Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlation between antibiotic use and resistance of gram-negative bacteria at a university hospital in Japan from 2013 to 2021: a study using the Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) system.
Kagami K, Ishiguro N, Iwasaki S, Taki K, Fukumoto T, Hayasaka K, Oyamada R, Watanabe T, Nakakubo S, Niinuma Y, Sugawara M, Takekuma Y. Kagami K, et al. Among authors: ishiguro n. Eur J Hosp Pharm. 2023 Jul 12:ejhpharm-2023-003797. doi: 10.1136/ejhpharm-2023-003797. Online ahead of print. Eur J Hosp Pharm. 2023. PMID: 37438092
Successful Colistin Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection Using a Rapid Method for Determination of Colistin in Plasma: Usefulness of Therapeutic Drug Monitoring.
Yamada T, Ishiguro N, Oku K, Higuchi I, Nakagawa I, Noguchi A, Yasuda S, Fukumoto T, Iwasaki S, Akizawa K, Furugen A, Yamaguchi H, Iseki K. Yamada T, et al. Among authors: ishiguro n. Biol Pharm Bull. 2015;38(9):1430-3. doi: 10.1248/bpb.b15-00323. Epub 2015 Jul 9. Biol Pharm Bull. 2015. PMID: 26155936 Free article.
Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant gram-negative bacilli.
Kagami K, Ishiguro N, Yamada T, Niinuma Y, Iwasaki S, Taki K, Fukumoto T, Hayasaka K, Oyamada R, Watanabe T, Nishida M, Sugita J, Teshima T, Sugawara M, Takekuma Y. Kagami K, et al. Among authors: ishiguro n. J Infect Chemother. 2021 Mar;27(3):473-479. doi: 10.1016/j.jiac.2020.10.024. Epub 2020 Nov 2. J Infect Chemother. 2021. PMID: 33144146
Clinical outcomes of intervention for carbapenems and anti-methicillin-resistant Staphylococcus aureus antibiotics by an antimicrobial stewardship team.
Kagami K, Ishiguro N, Yamada T, Niinuma Y, Iwasaki S, Taki K, Fukumoto T, Hayasaka K, Nishida M, Sugita J, Teshima T, Sugawara M, Takekuma Y. Kagami K, et al. Among authors: ishiguro n. Am J Infect Control. 2021 Dec;49(12):1493-1498. doi: 10.1016/j.ajic.2021.08.011. Epub 2021 Aug 17. Am J Infect Control. 2021. PMID: 34416316 Free article.
Three-day regimen of oseltamivir for post-exposure prophylaxis of influenza in hospital wards: a study protocol for a prospective, multi-center, single-arm trial.
Ishiguro N, Ito YM, Iwasaki S, Nagao M, Kawamura H, Kanai S, Nukui Y, Tokuda K, Miyara T, Igari H, Yamada K, Chikumi H, Sano C, Koike R, Yagi T, Murakami N; Japan Infection Prevention, Control Conference for National, Public University Hospitals. Ishiguro N, et al. BMC Infect Dis. 2021 Aug 30;21(1):887. doi: 10.1186/s12879-021-06602-w. BMC Infect Dis. 2021. PMID: 34461842 Free PMC article. Clinical Trial.
1,301 results